Clinical Trial Update: A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach Adenocarcinoma [Phase 2]

View source ↗

Summary

This is a Phase II clinical trial evaluating transarterial chemoembolization (TACE) in combination with a PD-1 antibody for locally advanced gastric cancer. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Advanced Gastric Cancer | Phase 2 | Status: RECRUITING